JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $2.42M | ﹤0.01% |
27,763
+4,493
| +19% | +$393K |
|
|
ABMD
3102
PUT
DELISTED
Abiomed Inc
ABMD
| $2.42M | ﹤0.01% |
+14,200
| New | +$2.63M |
|
3103
Stock Yards Bancorp
SYBT
$2.64B
| $2.42M | ﹤0.01% |
58,900
+19,423
| +49% | +$771K |
|
3104
CALL
Melco Resorts & Entertainment
MLCO
$2.14B
| $2.42M | ﹤0.01% |
+100,000
| New | +$2.17M |
|
|
SINA
3105
DELISTED
Sina Corp
SINA
| $2.42M | ﹤0.01% |
60,537
+16,642
| +38% | +$638K |
|
3106
Ultragenyx Pharmaceutical
RARE
$2.6B
| $2.41M | ﹤0.01% |
56,524
+35,368
| +167% | +$1.46M |
|
|
PS
3107
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $2.41M | ﹤0.01% |
140,189
+86,174
| +160% | +$1.47M |
|
3108
Spectrum Brands
SPB
$2.09B
| $2.41M | ﹤0.01% |
37,508
-147,394
| -80% | -$8.35M |
|
3109
Gibraltar Industries
ROCK
$1.45B
| $2.41M | ﹤0.01% |
47,743
+6,627
| +16% | +$333K |
|
3110
CALL
Northrop Grumman
NOC
$81.6B
| $2.41M | ﹤0.01% |
+7,000
| New | +$2.46M |
|
3111
CALL
Philip Morris
PM
$294B
| $2.41M | ﹤0.01% |
28,300
+19,300
| +214% | +$1.59M |
|
3112
Signet Jewelers
SIG
$3.6B
| $2.41M | ﹤0.01% |
110,761
-18,906
| -15% | -$336K |
|
3113
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
| $2.4M | ﹤0.01% |
99,213
-6,503
| -6% | -$156K |
|
|
HUYA
3114
Huya Inc
HUYA
$538M
| $2.4M | ﹤0.01% |
133,503
-43,599
| -25% | -$922K |
|
|
DBD
3115
DELISTED
Diebold Nixdorf Incorporated
DBD
| $2.38M | ﹤0.01% |
225,889
+41,125
| +22% | +$365K |
|
3116
Genpact
G
$5.78B
| $2.38M | ﹤0.01% |
56,531
-67,408
| -54% | -$2.69M |
|
|
VTLE
3117
DELISTED
Vital Energy
VTLE
| $2.38M | ﹤0.01% |
41,515
+652
| +2% | +$31.6K |
|
|
MGI
3118
DELISTED
MoneyGram International, Inc. New
MGI
| $2.38M | ﹤0.01% |
1,134,570
+235,339
| +26% | +$755K |
|
|
RDS.A
3119
CALL
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.38M | ﹤0.01% |
40,400
-55,600
| -58% | -$3.25M |
|
|
RDUS
3120
DELISTED
Radius Recycling
RDUS
| $2.38M | ﹤0.01% |
109,803
-53,391
| -33% | -$1.14M |
|
3121
Phibro Animal Health
PAHC
$1.38B
| $2.38M | ﹤0.01% |
95,788
-30,150
| -24% | -$700K |
|
3122
iShares MSCI Europe Financials ETF
EUFN
$4.3B
| $2.38M | ﹤0.01% |
121,972
+3,890
| +3% | +$72.2K |
|
3123
STAAR Surgical
STAA
$1.26B
| $2.37M | ﹤0.01% |
67,497
+42,372
| +169% | +$1.4M |
|
3124
CALL
Alaska Air
ALK
$5.3B
| $2.37M | ﹤0.01% |
35,000
| – | – |
|
|
3125
PUT
Alaska Air
ALK
$5.3B
| $2.37M | ﹤0.01% |
35,000
| – | – |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.